LLY · Analysis updated Oct 29, 2026, 10:45 AM ET

Why is Eli Lilly and Company (LLY) stock moving?

Lilly crushed expectations and raised its sales forecast by about $5 billion, on a day when money is flowing out of tech and into healthcare. The best company in the strongest sector just got better.

News behind the analysis

Eli Lilly (LLY) earnings Q3 2026
CNBC · Oct 28, 2026
Revenue $24.4B vs $22.61B expected; adjusted EPS $7.48; FY26 revenue guide raised to $91-92B; Foundayo below expectations.
Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases
24/7 Wall St. · Oct 28, 2026
Mounjaro +65%, Zepbound +49%; peer reaction; one-time benefits flagged as a quality question.
Eli Lilly (LLY) Stock Jumps 4% After Q3 Earnings Beat and Higher Revenue Outlook
CoinCentral · Oct 28, 2026
Premarket reaction; guide vs $88.8B consensus; prior estimate revisions mostly negative, which makes the beat sharper.
Eli Lilly Just Hit a 52-Week High. The October 29 Report Has to Prove Its Margins Hold
Yahoo Finance (TIKR) · Oct 26, 2026
Pre-earnings bar: guidance above $87B and margin trends; Dec 7 investor update.
Why Are Healthcare Stocks Hitting Record Highs in October 2026?
EBC Financial Group · Sep 30, 2026
Rotation from tech into healthcare; sector at records.

In the Daily Standout

October 29, 2026: the Daily Standout +6.95%

For informational and educational purposes only. Not investment advice. Prices are an intraday snapshot and move quickly; scores are model-style opinions, not guarantees. Do your own research.